We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Indian Drugmaker for Data Integrity Violations
FDA Warns Indian Drugmaker for Data Integrity Violations
Windlas Healthcare drew a warning letter from the FDA after agency investigators found serious data integrity violations at its API manufacturing facility in Uttarakhand, northern India.